BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19690775)

  • 1. E-cadherin and p63 immunoexpression in dysplastic lesions and urothelial carcinomas of the bladder.
    Stepan A; Mărgăritescu C; Simionescu C; Ciurea R
    Rom J Morphol Embryol; 2009; 50(3):461-5. PubMed ID: 19690775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway.
    Fukushima H; Koga F; Kawakami S; Fujii Y; Yoshida S; Ratovitski E; Trink B; Kihara K
    Cancer Res; 2009 Dec; 69(24):9263-70. PubMed ID: 19934319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P16, c-erbB2 and Ki67 immunoexpression in urothelial carcinomas of the bladder.
    Stepan A; Simionescu C; Mărgăritescu C; Ciurea R
    Rom J Morphol Embryol; 2011; 52(2):653-8. PubMed ID: 21655657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus.
    Ebrahimi M; Boldrup L; Wahlin YB; Coates PJ; Nylander K
    Oral Oncol; 2008 Jul; 44(7):634-8. PubMed ID: 17936670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of p63 in primary and secondary vulvar Paget's disease.
    Yanai H; Takahashi N; Omori M; Oda W; Yamadori I; Takada S; Matsuura H; Yoshino T
    Pathol Int; 2008 Oct; 58(10):648-51. PubMed ID: 18801085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
    Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression.
    Athanasopoulou A; Aroukatos P; Nakas D; Repanti M; Papadaki H; Bravou V
    Urol Oncol; 2013 Aug; 31(6):836-42. PubMed ID: 21868260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
    Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
    J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin÷CD44 immunophenotype in the epithelial-mesenchymal transition of bladder urothelial carcinomas.
    Stepan AE; Pirici D; Bălăşoiu M; Novac MB; Drocaş AI; Ciurea RN; Stepan D; Gheonea DI; Simionescu CE
    Rom J Morphol Embryol; 2015; 56(1):85-91. PubMed ID: 25826491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.
    Lim MG; Adsay NV; Grignon DJ; Osunkoya AO
    Mod Pathol; 2011 Feb; 24(2):241-7. PubMed ID: 20818341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma.
    Simionescu C; Mărgăritescu C; Surpăţeanu M; Mogoantă L; Zăvoi R; Ciurea R; Surlin P; Stepan A
    Rom J Morphol Embryol; 2008; 49(2):189-93. PubMed ID: 18516325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
    Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
    Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin expression in invasive urothelial carcinoma.
    Sun W; Herrera GA
    Ann Diagn Pathol; 2004 Feb; 8(1):17-22. PubMed ID: 15129905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.
    Owens SR; Greenson JK
    Am J Surg Pathol; 2007 Feb; 31(2):285-90. PubMed ID: 17255774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
    Esheba GE; Longacre TA; Atkins KA; Higgins JP
    Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
    Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cadherin switch assessment in the epithelial-mesenchymal transition of urothelial bladder carcinomas.
    Drocaş AI; Tomescu PI; Mitroi G; Drăgoescu PO; Mărgăritescu C; Stepan AE; Şurlin V; CrăiŢoiu Ş; Drocaş I; Ungureanu AM; Găman AE; Turculeanu A; Simionescu CE
    Rom J Morphol Embryol; 2016; 57(3):1037-1044. PubMed ID: 28002521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.
    Vered M; Allon I; Dayan D
    J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR and Her2/neu immunoexpression in papillary urothelial bladder carcinomas.
    Enache M; Simionescu CE; Stepan A
    Rom J Morphol Embryol; 2013; 54(1):137-41. PubMed ID: 23529321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
    Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
    Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.